Author: openjargon

Goodman Group (ASX: GMG) shares have been relatively positive performers this year.

Since the start of the year, the industrial property giant’s shares have risen approximately 4%.

This compares favourably to a largely flat performance from the S&P/ASX 200 Index (ASX: XJO).

But what’s to come for this popular stock? Could it deliver double-digit returns over the next 12 months? Let’s see what analysts are saying.

Could Goodman shares deliver big returns?

The broker community is overwhelmingly positive on Goodman, with many brokers having the equivalent of buy ratings on its shares.

One of those brokers is Bell Potter, which has a buy rating and $35.50 price target on them.

Based on the current Goodman share price of $32.17, this implies potential upside of 10% for investors over the next 12 months. It recently commented:

While we do have some question marks visà-vis leasing progress, extension of timelines and associated impact on earnings mix and booking of profits, the moat around the haves and have nots for scaled data centre players appears to be widening, recognising the scale and complexity of execution. Post pull back, GMG trades at a discount to its 5yr PE vs. ASX200 avg (28% prem. vs. 52% 5yr avg) with forward customer signings a key driver.

Who else is bullish?

The team at Morgan Stanley is another bull. Earlier this week, the broker put an overweight rating and $36.15 price target on its shares. This suggests that upside of 12% is possible between now and this time next year.

Another broker that is positive is Morgans. It has a buy rating and $36.00 price target, which offers similar upside. It commented:

GMG’s 3Q26 update reinforced a deliberate strategy: deploy balance-sheet capital ahead of customer commitments to win the race for power-enabled metro data centre (DC) capacity. WIP is set to step from $14.5bn at Mar-26 to a record c.$18bn by Jun-26 (Consensus $17.7bn), with the power bank lifted to 6.4GW.

Operationally the update was mixed, with pre-committed share, production rate and Yield On Cost (YOC) all relatively flat hoh. The structurally important note was management’s view that industry DC capex requirements likely exceed global capital market funding capacity, a backdrop that favours those with secured power, sites and locked-in capital partners. FY26 OEPSg guided to ‘at least 9%’ (prior 9%; MorgansF 9.2%; Consensus 9.8%), marginally up.

Finally, the team at Citi has a buy rating and $40.00 price target on Goodman shares. This implies potential upside of approximately 24% for investors over the next 12 months.

The post Could Goodman shares rise more than 20%? appeared first on The Motley Fool Australia.

More reading

• Where to invest your Westpac dividends
• 8 ASX 200 shares with reaffirmed buy recommendations this week
• These ASX shares are riding the AI boom. Investors keep overlooking them
• The ASX investing strategy that could quietly make you rich
• New to investing? 3 ASX shares to set and forget until 2036

Motley Fool contributor James Mickleboro has positions in Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It has been another painful day for shareholders of Judo Capital Holdings Ltd (ASX: JDO) shares.

The ASX bank stock extended its heavy sell-off on Friday morning, falling another 2% to $0.90 after already shedding around 40% over recent trading sessions.

That leaves Judo Capital shares down roughly 49% in 2026 and 42% over the past 12 months. By comparison, the S&P/ASX 200 Index (ASX: XJO) has gained approximately 2.2% over the same period.

So, what’s behind the dramatic collapse?

Investors didn’t like Judo’s latest update

The sell-off began after Judo released revised expectations for FY 2026 on Thursday that left investors questioning the bank’s near-term outlook.

While management still expects earnings to grow this financial year, it also revealed that bad debt costs are rising faster than previously anticipated.

The biggest concern was the bank’s updated cost of risk guidance. Judo now expects its FY 2026 cost of risk to come in between $116 million and $122 million, reflecting an increase in specific loan provisions.

Management of Judo Capital shares said the higher provisioning relates primarily to three individual customer exposures across different industries that have deteriorated following customer-specific developments.

Although the issues appear concentrated rather than widespread, investors rarely welcome surprises when it comes to credit quality.

The bank also expects loans that are either more than 90 days overdue or classified as impaired to rise to around 3% of gross loans and advances by 30 June. That’s another sign that some borrowers are finding conditions increasingly challenging.

There were a few positives

The update wasn’t entirely negative. Judo said its collective provision coverage should remain broadly unchanged from its third-quarter trading update, equating to 94 basis points of gross loans and advances.

Management also noted that current provisioning includes additional overlays designed to protect against ongoing macroeconomic uncertainty across vulnerable sectors.

In other words, Judo Capital believes it has built a reasonable buffer against further deterioration.

Profit growth is still expected, just not as much

Perhaps the biggest disappointment for investors in Judo Capital shares was a downgrade to earnings guidance. Judo now expects FY 2026 profit before tax of between $163 million and $169 million.

While that would still represent approximately 30% growth on FY 2025, it falls well short of the bank’s previous guidance of $180 million to $190 million.

Looking further ahead, management of the $2 billion ASX share expects FY 2027 profit before tax of between $210 million and $220 million, implying another year of roughly 30% earnings growth despite ongoing macroeconomic and geopolitical uncertainty.

Chief Executive officer Chris Bayliss acknowledged the disappointment but maintained confidence in the business. He said the latest update was partly driven by the broader economic backdrop but stressed that Judo Capital remains profitable, well capitalised, and has a clear pathway to delivering a return on equity in the low-to-mid teens.

What’s next for Judo Capital shares?

For now, investors appear focused on rising credit losses rather than future profit growth.

The market has become far less forgiving of banks reporting deteriorating loan quality, particularly when expectations were already high.

That said, Judo’s long-term growth story hasn’t disappeared overnight. The lender continues to grow its business banking franchise, remains profitable, and is forecasting another two years of double-digit earnings growth.

The post What on earth’s going on with Judo Capital shares? appeared first on The Motley Fool Australia.

More reading

• 8 ASX 200 shares with reaffirmed buy recommendations this week
• Why Judo Capital, Minerals 260, Santos, and Worley shares are dropping today
• Which ASX 200 bank stock is crashing 46% on profit guidance downgrade?
• RBA keeps cash rate at 4.35% – What does it mean for investors?
• Broker names 3 ASX shares to buy now

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Ramsay Health Care Ltd (ASX: RHC) shares are edging lower today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $42.74. In late morning trade on Friday, shares are changing hands for $42.65 apiece, down 0.2%.

For some context, the ASX 200 is just about flat at this same time.

Taking a step back, Ramsay Health Care shares have strongly outperformed in 2026, up 23.3% compared to the 0.3% year to date gains posted by the benchmark index.

And the ASX 200 healthcare stock also recently increased its passive income payouts, boosting its fully franked interim dividend by 6.3% to 42.5 cents a share.

Ramsay Health Care stock currently trades on a 1.9% fully franked trailing dividend yield.

And looking ahead, Nathan Hughes, an Australian equities portfolio manager at Perpetual, believes there’s plenty more upside potential for the Aussie-focused healthcare provider (courtesy of The Australian Financial Review).

Here’s why.

Should I buy Ramsay Health Care shares today?

Asked which stock his fund holds that’s most undervalued by the market, Hughes replied, “Ramsay Health Care presents compelling upside.”

He noted, “The negatives, such as labour inflation and changes to private health insurance rebates that may impact industry participation, are now well understood.”

And Ramsay Health Care shares could benefit from their renewed focus on the Aussie market.

According to Hughes:

Beyond the demerger of the Ramsay Santé assets – the European hospitals business Ramsay announced it would spin off in February – we think it’s clear the focus of the company is the core Australian business.

There is significant opportunity to improve operating performance and asset productivity in this division, with a sensible approach to capacity and utilisation in contrast to years of expansion. As such, return on invested capital should improve.

Hughes also pointed to the company’s strong balance sheet and the fully franked dividend on offer as reasons to be optimistic for ongoing share price growth.

He concluded:

Further capital repatriation from offshore is not out of the question in the medium term. This would give the company plenty of financial flexibility, noting Ramsay has a large balance of surplus franking credits.

What’s the latest from the ASX 200 healthcare stock?

Ramsay reported its half year results (H1 FY 2026) on 26 February.

Highlights for the six months to 31 December included underlying earnings before interest and tax (EBIT) of $536.7, up 7.3% year on year.

And on the bottom line, underlying net profit after tax (NPAT) of $171.7 million increased by 8.1%.

Ramsay Health Care shares closed up 10.4% on the day of the results release.

The post Up 23% this year, why Ramsay Health Care shares are tipped for more ‘compelling upside’ appeared first on The Motley Fool Australia.

More reading

• Ramsay Health Care shares rebound 15% in June: Can they keep going?
• Healthcare shares led the ASX 200 last week. Is a sector comeback underway?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Recce Pharmaceuticals Ltd (ASX: RCE) shares are being hammered on Friday after the ASX biotech company released an update.

At the time of writing, the Recce share price is down a massive 18.48% to 37.5 cents.

That leaves the ASX healthcare stock down 40% since the start of 2026, wiping out a large chunk of its earlier momentum. However, the stock is still up 25% over the past year.

The latest announcement appears to have rattled investors, raising questions about Recce’s funding needs and whether the market is losing patience.

Recce is developing synthetic anti-infectives designed to address antimicrobial-resistant infections.

The capital raise behind the sell-off

According to the release, Recce has received firm commitments to raise $4 million before costs through an institutional placement.

The company will issue 10 million new shares at 40 cents per share.

The placement price appears to be the sticking point for investors. It is slightly above the current share price, but still well below where Recce shares were trading before the update.

Reece is also launching a share purchase plan (SPP) to raise up to another $4 million. Eligible shareholders can apply for up to $30,000 worth of new shares on the same terms as the placement.

Investors taking part in the placement and SPP will also receive one free attaching option for every two new shares issued. These options will have an exercise price of 60 cents and expire on 30 June 2027.

On top of that, holders who exercise those attaching options will receive two piggyback options, with an exercise price of $1 and an expiry date of 30 June 2028.

Where the money is going

Recce said the funds will be used across several parts of the business.

The cash will help strengthen its balance sheet, support commercial licensing work with a leading Middle Eastern pharmaceutical company, and fund clinical trials.

The company pointed to ongoing work on diabetic foot infections, including a Phase 3 registration trial in Indonesia and another in Australia.

Funds will also go toward activities linked to an Investigational New Drug application with the US Food and Drug Administration (FDA) and Indonesia’s BPOM.

After the offer, Recce expects pro forma cash liquidity of approximately $29.5 million before offer costs.

Can Recce win back investors?

Capital raisings can be very hard for smaller biotech companies, especially when commercial revenue is still limited.

Recce’s market capitalisation is now about $108 million, so a potential $8 million raise is definitely meaningful.

The company now needs to show that this funding can support clinical progress, regulatory work, and commercial deals. 

Until then, it looks like investors are staying on the sidelines.

The post Guess which ASX stock is crashing 18% today appeared first on The Motley Fool Australia.

More reading

• Where to invest your Westpac dividends
• Own Vanguard ASX ETFs? Here is your next dividend
• Could Goodman shares rise more than 20%?
• What on earth’s going on with Judo Capital shares?
• Up 23% this year, why Ramsay Health Care shares are tipped for more ‘compelling upside’

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are just inside the green, up 0.03%, at 8,752.1 points on Friday.

This week, brokers have renewed their buy ratings and updated their 12-month price targets on several ASX 200 shares.

Let’s take a look.

Judo Capital Holdings Ltd (ASX: JDO)

The Judo share price is 90 cents, down 1.6% today.

This ASX 200 bank share was smashed yesterday, collapsing 46% on a profit guidance downgrade.

Today, Morgans renewed its buy rating on Judo shares but slashed its 12-month target price from $2.15 to $1.47.

This implies a potential bounce back of more than 60% over the next year.

Morgans said:

JDO downgraded its FY26 PBT guidance by c.8% at the mid-point. Even more disappointing was first-time FY27 PBT guidance which was c.16% below expectations at the mid-point.

The share price drawdown was vicious (particularly considering the decline that had already occurred since February).

While the earnings growth outlook has moderated, we still forecast c.30% EPS growth across both FY26 and FY27 with the stock now trading on a c.6.8x PER (FY27F) and 0.6x P:BV (end-FY26).

A significant risk premium or probability of failure has been priced into the stock. BUY.

BHP Group Ltd (ASX: BHP)

The BHP share price is $57.17, up 1.1% today.

The market’s largest ASX 200 mining share has lifted 29% in the year to date (YTD).

BHP shares have dropped almost 10% since last Thursday amid news of a $2.8 billion cost blow-out at its Jansen potash project.

Morgan Stanley reiterated its buy rating on BHP shares with a price target of $67.50.

This implies a potential 14% upside ahead.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price is $10.65, down 0.6% on Friday.

The ASX 200 airline share has ripped 18% over the past month.

Ord Minnett reiterated its buy rating on Qantas shares this week.

The broker raised its 12-month price target from $10.50 to $11.50.

This suggests a potential 8% upside ahead.

Goodman Group (ASX: GMG)

The Goodman share price is $32.06, down 0.4% today.

The ASX 200’s biggest real estate share has risen 4% YTD.

Citi renewed its buy rating on Goodman shares with a $40 target yesterday.

This suggests a potential 25% upside ahead.

NextDC Ltd (ASX: NXT)

The NextDC share price is $14.44, down 1.9% today.

This ASX 200 tech share has risen 17% YTD amid a broader sector rebound.

Citi reiterated its buy rating on NextDC shares with a price target of $19.10.

This implies potential capital growth of 32% ahead.

Electro Optic Systems Holdings Ltd (ASX: EOS)

Electro Optic Systems shares are $9.33, down 2.8% today.

The ASX 200 defence share has lost 6% of its market valuation YTD.

Bell Potter renewed its buy rating on Electro Optic Systems shares this week.

The broker increased its 12-month price target from $10.60 to $12.50.

This suggests a potential 34% upside ahead.

Lynas Rare Earths Ltd (ASX: LYC)

The Lynas Rare Earths share price is $19.02, up 1.7% today.

This ASX 200 rare earths share has ripped 56% higher YTD.

UBS upgraded Lynas Rare Earths shares to a buy rating with a $23.65 target on Thursday.

This implies a potential 24% upside ahead.

Insurance Australia Group Ltd (ASX: IAG)

The IAG share price is $8.12, down 1.2% today.

Over the past month, this ASX 200 financial share has lifted 8%.

Goldman Sachs reiterated its buy rating on IAG shares with an $8.60 target yesterday.

This suggests a potential 6% upside ahead.

The post 8 ASX 200 shares with reaffirmed buy recommendations this week appeared first on The Motley Fool Australia.

More reading

• What’s next for BHP shares? Broker forecasts revealed
• Here are the top 10 ASX 200 shares today
• Why Judo Capital, Minerals 260, Santos, and Worley shares are dropping today
• Why A2 Milk, EchoIQ, Lendlease, and Qantas shares are racing higher today
• Which ASX 200 bank stock is crashing 46% on profit guidance downgrade?

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems, Goldman Sachs Group, and Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has recommended BHP Group and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) shares are down 0.5% to $161.82, while CSL Ltd (ASX: CSL) is down 1% to $116.48 on Friday.

In a newsletter this week, Blackwattle Large Cap Quality Fund portfolio managers, Joe Koh and Elan Miller, explain why they are underweight on the market’s largest ASX 200 bank share and overweight on the market’s biggest healthcare share.

If you’re unfamiliar with the lingo, underweight and overweight compare a fund manager’s holding in an ASX stock to its weighting in the benchmark index.

If a fund manager is overweight a stock, they hold a larger proportion of that stock than the benchmark index does.

The Large Cap Quality Fund aims to outperform the S&P/ASX 200 Accumulation Index (ASX: XJOA), after fees, over the long term.

CBA shares

CBA shares represents 10.2% of the ASX 200 Accumulation Index’s market capitalisation.

Koh and Miller said they are underweight CBA shares, and this helped the fund outperform the market in May.

They commented:

CBA provided a Q3 update, which saw its cash earnings narrowly miss consensus estimates by 1%, notwithstanding stable net interest margins and robust home lending growth of 7.1% and business lending growth of +12.5%, year-on-year.

The small earnings disappointment, combined with (in our view) expensive valuation and uncertainty around housing due to negative gearing tax changes, saw CBA’s shares underperform the S&P/ASX 200 index in May.

The night before CBA’s update, the Federal Government proposed a raft of tax changes in the 2026-27 Budget.

CBA shares experienced their biggest daily fall ever, dropping 10.2% and descending to No. 2 in the S&P/ASX 200 Index (ASX: XJO).

Koh and Miller said the Federal Budget marked “the biggest changes to the tax system since the introduction of the GST”.

The changes include replacing the 50% capital gains tax (CGT) discount for assets held longer than 12 months with a cost base inflation indexation method and a minimum 30% CGT rate; and limiting negative gearing to new builds, effective 1 July next year.

Koh and Miller expect this to adversely affect ASX 200 bank shares.

… we anticipate slower credit growth moving forward, as well as increased risk of bad and doubtful debts, given that individuals are already feeling the impact of the RBA’s rate hikes, higher fuel prices, and increased inflation.

We believe the Budget will place increased pressure on the banks’ operating margins, increasing the risk of earnings downgrades.

The managers pointed out:

Australian home loans comprise about 63% of CBA’s total loan book, of which about one third is to investors.

CBA shares are up 0.4% in the calendar year to date (YTD) compared to a 0.3% rise for the ASX 200.

CSL shares

ASX 200 healthcare shares appear to be staging a comeback after a horror 12 months amid many industry challenges.

The S&P/ASX 200 Health Care Index (ASX: XHJ) appears to have hit a pivot point on 3 June when it touched a 9-year low.

At that stage, ASX 200 healthcare shares had fallen by more than 40% over 12 months.

Since then, healthcare shares have risen 15% as value investors return to the sector, hunting bargains.

CSL shares have been a clear target, lifting 26% since 3 June.

The CSL share price commenced a downward spiral in early FY25 amid far bigger problems than sector weakness.

Koh and Miller said CSL downgraded its earnings forecast again in May after previously reaffirming guidance when the then-CEO resigned.

The managers said:

CSL now expects FY26 revenue to be around $15.2 billion (market expectations were $15.8bn) and NPATA (excluding restructuring costs and impairments) to be around $3.1 billion (market expectations were $3.35bn), both on a constant currency basis.

CSL also intends to recognise approximately $5 billion of non-cash, pre-tax impairments across FY26 and FY27, in addition to those
announced at the FY26 half-year results.

The market continues to be wary of CSL, as the new CEO is yet to be named and the competitive environment remains difficult.

Despite this, Koh and Miller have faith that this former ASX 200 blue-chip company can pull itself out of the mud.

While previously underweight this stock, the Fund has recently moved to a small overweight position given the stock’s
now more attractive valuation, which sits at a substantial discount to the ASX 200.

CSL shares are down 32% YTD and make up 2.1% of the ASX 200 Accumulation Index.

The post Why this fundie is overweight CSL and underweight CBA shares appeared first on The Motley Fool Australia.

More reading

• 3 ASX blue chip shares to buy and hold for the next 20 years
• Once untouchable, now unloved: What’s up with CSL shares?
• $10,000 invested in CSL shares 12 months ago is now worth…
• Why I’d buy CSL and Zip shares before they recover
• New to ASX shares? Avoid these 3 beginner mistakes

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Regis Resources Ltd (ASX: RRL) shares are charging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) gold stock closed yesterday trading for $6.45. In morning trade on Friday, shares are swapping hands for $6.58 apiece, up 3.2%.

For some context, the ASX 200 is up 0.1% at this same time.

This outperformance follows the release of Regis’ mid-year exploration update.

Here’s what’s grabbing investor interest.

Regis Resources shares lift on growth outlook

Year to date, the ASX 200 gold miner said it continued advancing priority underground and open pit targets. Regis reported this has improved its geological confidence across key growth areas as it assesses longer-term opportunities at its Duketon, McPhillamys, and Tropicana gold mines.

Regis Resources shares could get longer-term support from Duketon, with the miner declaring the initial open pit Mineral Resource declared for Beamish South. That came out at 7 million tonnes at 1.1 grams of gold per tonne for 270,000 ounces.

Also at Duketon, the miner said recent drilling at Garden Well and Rosemont Stage 3 have confirmed strong mineralisation. And ongoing drilling at Ben Hur supports the view of a potential underground mining opportunity.

At Kings Plains, situated close to the McPhillamys project, recent drilling results were said to support the potential for an open pit resource.

Regis Resources added that diamond drilling within its Tropicana Underground project continued to increase its confidence in the known mineralisation.

What did management say?

Commenting on the results helping boost Regis Resources shares today, CEO Jim Beyer said, “Regis holds a significant pipeline of opportunities, with almost 100 exploration prospects and projects at varying stages of maturity the subject of prioritised evaluation and testing across our portfolio.”

Beyer added:

At Duketon, we are encouraged by the initial Mineral Resource Estimate declared at Beamish South, and drilling will continue as we work to grow that Resource and assess its potential to support a future Ore Reserve. Ongoing drilling at Garden Well, Rosemont and Ben Hur continues to demonstrate the opportunity within the Duketon portfolio and we remain confident in our long-term underground growth pipeline.

At Tropicana, drilling across Boston Shaker, Tropicana Underground, Havana South and the Swizzler area has returned encouraging results, further reinforcing our view of Tropicana as an asset with meaningful exploration upside.

These results, including the initial Kings Plain depth extension testing, continue to validate our exploration strategy and reinforce our belief in the quality and scale of Regis’ asset base.

Looking to what could impact Regis Resources shares in the months ahead, Beyer concluded, “We see meaningful potential to grow our resource base and continue to extend mine life across the business.”

The post Regis Resources shares leaping higher today on gold mine growth outlook appeared first on The Motley Fool Australia.

More reading

• 2 ASX gold shares making big moves on key updates
• 7 ASX gold stocks to buy now
• Why Clinuvel, Elevra Lithium, Regis Resources, and SCEE shares are racing higher today
• Here are the top 10 ASX 200 shares today
• Vault Minerals lifts earnings, initiates dividend, and announces merger with Regis

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

A small-cap ASX miner is turning heads on Friday after releasing an update that has gone down well with the market.

At the time of writing, the Ioneer Ltd (ASX: INR) share price is up 7.14% to 15 cents.

Despite the gain, it has been a rollercoaster ride for shareholders. The stock is still down around 19% in 2026, but it has jumped 54% over the past 12 months.

The latest release seems to have hit the right note, with critical minerals still a major focus in the US.

Here’s what Ioneer announced.

Ioneer lands US Army-linked award

In a statement to the ASX, Ioneer said it received a conditional US Army award for land at Utah’s Toole Army Depot.

The company said the long-term lease would support the development of a critical mineral processing facility.

Fortunately, Ioneer was one of four companies selected, alongside Empire State Mines, EnergyX and REalloys.

The US Army is looking to use parts of its land to help build more domestic processing capacity for critical minerals. These include lithium, boron, graphite and rare earths, which are used across defence, energy and advanced manufacturing supply chains.

Ioneer said the award is tied to its Rhyolite Ridge Lithium-Boron Project in Nevada.

The company describes Rhyolite Ridge as the largest undeveloped boron ore reserve in the world outside Turkey. It also said the project is the only known lithium-boron deposit in North America.

Why this is a big deal

The land lease is useful, but this update is really about the bigger opportunity around Ioneer.

The US is trying to build more mineral processing capacity at home, especially for materials used in defence, energy and advanced manufacturing.

And this is where Rhyolite Ridge stands out.

It’s not just another lithium project. It has a large boron resource, which gives Ioneer another way into America’s supply chain push.

Boron doesn’t get mentioned as much as lithium. However, Ioneer said it is used in military armour, high-strength magnets, semiconductors and nuclear applications.

The company also noted that the US government added boron to its list of critical minerals in November 2025.

The US Army release said “The ability to process critical minerals on U.S. soil is a national-defence priority required for munitions, missiles, sensors, batteries, and the platforms our soldiers depend on.”

What investors will be watching now

While today’s update is a positive one, there is still plenty of work ahead.

Keep in mind that the lease award is conditional, and Ioneer still needs to keep moving Rhyolite Ridge toward development.

This means attention turns to progress on funding, approvals, construction plans and a final investment decision (FID).

Fortunately, there has been some progress on that front.

Recent reports have pointed to support from South Korean groups Hyundai Engineering and Korea Overseas Infrastructure & Urban Development for the project.

The post This small-cap ASX stock is soaring after a major US Army boost appeared first on The Motley Fool Australia.

More reading

• Forget PLS shares, this US-focused ASX lithium share could rise 100%+
• 5 things to watch on the ASX 200 on Thursday
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Guess which ASX lithium share is jumping 25% on big news

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The DigiCo Infrastructure REIT (ASX: DGT) share price is in focus today after the company announced the resignation of its Chief Executive Officer, Mr Michael Juniper, effective immediately. The Board has commenced a search for a new CEO, with the existing leadership team maintaining day-to-day operations.

What did DigiCo Infrastructure REIT report?

• Mr Michael Juniper has stepped down as CEO and Director, effective 26 June 2026
• The Board is conducting a formal executive search for a permanent CEO
• The leadership team remains in place to ensure continuity
• No earnings or dividend updates were provided in this announcement

What else do investors need to know?

DigiCo Infrastructure REIT first announced Mr Juniper was on extended personal leave in March 2026. His departure marks a significant leadership transition for DGT, but the company’s strategy and ongoing operations will continue under the current management team while a successor is sought.

The Board thanked Mr Juniper for his contributions and highlighted its commitment to maintaining stability throughout the leadership transition. Both internal and external candidates will be considered for the CEO position.

What’s next for DigiCo Infrastructure REIT?

DigiCo Infrastructure REIT remains focused on executing its strategy as a diversified owner, operator and developer of data centres. The Board is prioritising a thorough CEO search process to ensure a smooth leadership transition and ongoing delivery of value for investors.

As the executive search gets underway, the existing leadership team is expected to ensure operational stability and drive the company’s plans in the short term.

DigiCo Infrastructure REIT share price snapshot

Over the past 12 months, DigiCo Infrastructure REIT shares have declined 30%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post DigiCo Infrastructure REIT CEO resigns appeared first on The Motley Fool Australia.

More reading

• Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate
• Transurban Group announces major North America project expansion
• Ampol launches new $400m subordinated notes facility
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Centuria Capital Group (ASX: CNI) share price is in focus today as the company opens its $35 million retail entitlement offer, following a strong $65 million institutional component and reaffirms FY26 earnings guidance.

What did Centuria Capital Group report?

• Launched a $35 million fully underwritten retail entitlement offer at $2.00 per security
• Raised $65 million from institutional investors as part of a $100 million entitlement offer
• Institutional placement raised an additional $200 million, bringing total new equity to $300 million
• FY26 operating earnings guidance reaffirmed at 13.6 cents per security, an 11.5% increase on FY25
• Offer price represents a 6.0% discount to the last close and a 5.2% discount to the adjusted TERP
• Pro-forma net asset value to rise to $1.81 per security, with pro-forma gearing reduced to 3.4%

What else do investors need to know?

The retail entitlement offer gives eligible retail investors the chance to buy 1 new Centuria security for every 17 they own, priced at $2.00 each. Investors who take up their full allocation can also apply for up to 25% more through a top-up facility, though allocations may be scaled back at the company’s discretion.

Proceeds from the $300 million total equity raising are earmarked to accelerate Centuria’s growth ambitions across both its specialist data centre platform, ResetData, and its real estate and private credit fund management business. Centuria’s recent strategic moves include scaling its Australian AI Factory capabilities and acquisition of larger real estate assets to seed new funds.

What did Centuria Capital Group management say?

Joint CEOs John McBain and Jason Huljich commented:

The Centuria and ResetData combination has created a differentiated NVIDIA neocloud partner with scalable sovereign AI Factories and access to Centuria’s real estate, land and potential 200MW+ power pipeline. ResetData is one of three Australian NVIDIA Cloud Partners and is uniquely placed to take advantage of an upswing in international demand for the establishment of Australian-based AI Factory capacity uptake.

What’s next for Centuria Capital Group?

Looking ahead, Centuria will focus on deploying new funds into its ResetData pipeline, targeting accelerated development of AI Factory data centres and onboarding enterprise and government customers seeking sovereign compute capacity. Further growth is expected as Centuria expands its credit funds management and continues scaling up its real estate platform with larger fund launches and property acquisitions.

Management reconfirmed its disciplined approach to capital allocation and flagged balance sheet flexibility will support future organic and inorganic growth opportunities, while the new securities will rank equally with existing ones (except for the June 2026 distribution).

Centuria Capital Group share price snapshot

Over the past 12 months, Centuria Capital Group shares have risen 16%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate appeared first on The Motley Fool Australia.

More reading

• Transurban Group announces major North America project expansion
• Ampol launches new $400m subordinated notes facility
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.